44 Stocks Moving In Monday’s Mid-Day Session
Gainers
Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares climbed 43.5% to $127.44 after the company announced positive clinical data for its CRISPR therapy.
QIAGEN Launches Dedicated CRISPR Products for Rapid and Simplified Analysis of Gene-Editing Experiments
QIAprep& CRISPR Kit and Q-Primer Solutions expand QIAGEN portfolio for CRISPR applications
Products are highly sensitive tools for characterizing the impact of CRISPR editing experiments
Solutions
Cathie Wood’s ARK Invest Posts Fund Purchases For Thursday, June 17, 2021: CMIIU, CRSP, QSI, PD, BLDE, IRDM, KTOS, PATH
CM Life Sciences (CMIIU) - 556,195 Shares
Crispr Therapeutics (CRSP) - 5,400
Quantum-Si (QSI) - 688,036
PagerDuty (PD) - 22,658
Blade Air Mobility (BLDE) - 149,784
Iridium Communications (IRDM) -
Cramer Gives His Opinion On Bank of America, Advanced Micro Devices And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Martin Marietta Materials, Inc. (NYSE: MLM) is a well-run company.
CRISPR Therapeutics, Capsida Collaborate To Develop Gene-Edited Therapies For Neurological Diseases
CRISPR Therapeutics (NASDAQ:CRSP) has signed a deal with Capsida Biotherapeutics, a gene therapy player specializing in AAV engineering, to carve out a…
CRISPR Therapeutics and Capsida Biotherapeutics Announce Strategic Collaboration to Develop Gene-Edited Therapies for Amyotrophic Lateral Sclerosis and Friedreich’s Ataxia
CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, and Capsida Biotherapeutics Inc., a biotechnology company dedicated to
10 Biggest Price Target Changes For Monday
Needham raised OrthoPediatrics Corp. (NASDAQ: KIDS) price target from $70 to $77. Vertex Pharmaceuticals shares rose 0.2% to close at $63.51 on Friday.
Citigroup Upgrades CRISPR Therapeutics to Neutral, Raises Price Target to $132
Citigroup analyst Yigal Nochomovitz upgrades CRISPR Therapeutics (NASDAQ:CRSP) from Sell to Neutral and raises the price target from $55 to $132.